Effects of cold atmospheric plasma on viability of breast (MDA-MB-231) and cervical (Hela) cancer cells

authors:

avatar Mahya Aminraya Jezeh , avatar Mohammadreza Khani , avatar Hassan Niknejad , * , avatar Babak Shokri

Koomesh: Vol.21, issue 4; 694-701
published online: December 01, 2019
article type: Research Article
received: May 07, 2018
accepted: April 01, 2019

how to cite: Aminraya Jezeh M, Khani M, Niknejad H, Shokri B. Effects of cold atmospheric plasma on viability of breast (MDA-MB-231) and cervical (Hela) cancer cells. koomesh. 2019;21(4):e153134. 

Abstract

Introduction: There are many reports published about the use of cold atmospheric plasma in cancer treatment recently. In this way, the selective effects of cold plasma on the breast (MDA-MB-231) and cervical (Hela) cancer cells were studied as a new cancer treatment method. Materials and Methods: In this study, cold atmospheric pressure plasma was generated using a plasma jet reactor and also optical emission spectroscopy (OES) was used to investigate the free radicals produced by the plasma. Futhermore, the effects of helium and helium-oxygen gas mixtures and the time of plasma radiation on the viability of MDA-MB-231 and Hela cells immediately, 24 and 48 hours after radiation were determined by MTT assay. In this account, in order to investigate the selective effects of plasma, direct treatment method was used to evaluate the viability of normal fibroblast cell line. Results: The results of optical emission spectroscopy showed that decreasing the sample distance from the plasma jet nozzle and increasing operating voltage increased the free radicals produced by plasma. Increasing the time of direct plasma radiation from one to five minutes reduced the vitality of the cancer cells. The most anti-cancer response was observed 48 hours after plasma irradiation and in the helium-oxygen gas mixture. Also, the results showed that cancer cells are more sensitive than normal fibroblast cells to plasma treatment. Conclusion: According to the promising results of this study, reducing the viability of cancer cells and fewer toxic effect on normal cells, cold plasma therapy can be considered as a new method for cancer therapy.  

References

  • 1.

    Abdollahzadeh R, Moodi M, Khanjani N. Investigating the mental experience of patients suffering from cancer. Jundishapur J Chronic Dis Care 2017; 6.

  • 2.

    Shademani M, Nassiri Koopaei N, Shirzad Yazdi N, Azizian H, Mousavi Z, Salimi M, et al. Anti-proliferative effects of new synthesized hydrazone derivatives on breast, colon and hepatic cancer cells. Koomesh 2018; 20: 725-730. (Persian).

  • 3.

    Sarizadeh MS, Mozaffari S, Rahimian boogar I. Effectiveness of acceptance and commitment therapy on the fear of cancer recurrence and post-traumatic growth among patients with breast cancer. Koomesh 2018; 20: 626-632. (Persian).

  • 4.

    Hajiesmaeil M, Tafvizi F, Sarmadi S. The association between methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer. Koomesh 2016; 17: 651-659. (Persian).

  • 5.

    Ratovitski EA, Cheng X, Yan D, Sherman JH, Canady J, Trink B, et al. Anticancer therapies of 21st century: novel approach to treat human cancers using cold atmospheric plasma. Plasma Process Polym 2014; 11: 1128-1137.

  • 6.

    Niknejad H, Yazdanpanah G, Ahmadiani A. Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angiogenesis make human amnion-derived cells promising sources for cell therapy of cancer. Cell Tissue Res 2016; 363: 599-608.

  • 7.

    Niknejad H, Yazdanpanah G. Anticancer effects of human amniotic membrane and its epithelial cells. Med Hypotheses 2014; 82: 488-489. (Persian).

  • 8.

    Fridman A. Plasma chemistry: Cambridge university press; 2008.

  • 9.

    Cooper M, Fridman G, Staack D, Gutsol AF, Vasilets VN, Anandan S, et al. Decontamination of surfaces from extremophile organisms using nonthermal atmospheric-pressure plasmas. IEEE Transac Plasma Sci 2009; 37: 866-871.

  • 10.

    Sun P, Sun Y, Wu H, Zhu W, Lopez JL, Liu W, et al. Atmospheric pressure cold plasma as an antifungal therapy. Applied Physics Letters. 2011;98(2):021501.

  • 11.

    Mitra A, Morfill GE, Shimizu T, Steffes B, Isbary G, Schmidt H-U, et al. Applications in plasma medicine: a SWOT approach. Composite Interfaces. 2012;19(3-4):231-8.

  • 12.

    Babington P, Rajjoub K, Canady J, Siu A, Keidar M, Sherman JH. Use of cold atmospheric plasma in the treatment of cancer. Biointerphases. 2015;10(2):029403.

  • 13.

    Chang JW, Kang SU, Shin YS, Kim KI, Seo SJ, Yang SS, et al. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G 1 arrest via the ATM/p53 pathway. Archives of biochemistry and biophysics. 2014;545:133-40.

  • 14.

    Tanaka H, Mizuno M, Ishikawa K, Takeda K, Nakamura K, Utsumi F, et al. Plasma medical science for cancer therapy: Toward cancer therapy using nonthermal atmospheric pressure plasma. IEEE Transactions on Plasma Science. 2014;42(12):3760-4.

  • 15.

    Yan D, Talbot A, Nourmohammadi N, Cheng X, Canady J, Sherman J, et al. Principles of using cold atmospheric plasma stimulated media for cancer treatment. Scientific reports. 2015;5.

  • 16.

    Huang J, Chen W, Li H, Wang X-Q, Lv G-H, Khohsa ML, et al. Deactivation of A549 cancer cells in vitro by a dielectric barrier discharge plasma needle. Journal of Applied Physics. 2011;109(5):053305.

  • 17.

    Akhlaghi M, Rajaei H, Mashayekh AS, Shafiae M, Mahdikia H, Khani M, et al. Determination of the optimum conditions for lung cancer cells treatment using cold atmospheric plasma. Physics of Plasmas. 2016;23(10):103512.

  • 18.

    Torii K, Yamada S, Nakamura K, Tanaka H, Kajiyama H, Tanahashi K, et al. Effectiveness of plasma treatment on gastric cancer cells. Gastric cancer. 2015;18(3):635-43.

  • 19.

    Yonson S, Coulombe S, Leveille V, Leask R. Cell treatment and surface functionalization using a miniature atmospheric pressure glow discharge plasma torch. Journal of Physics D: Applied Physics. 2006;39(16):3508.

  • 20.

    Brull L, Vandamme M, Ris D, Martel E, Robert E, Lerondel S, et al. Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PloS one. 2012;7(12):e52653.

  • 21.

    Lupu A-R, Georgescu N, Clugru A, Cremer L, Szegli G, Kerek F. The effects of cold atmospheric plasma jets on B16 and COLO320 tumoral cells. Roum Arch Microbiol Immunol. 2009;68(3):136-44.

  • 22.

    Iida M, Yajima I, Ohgami N, Tamura H, Takeda K, Ichihara S, et al. The effects of non-thermal atmospheric pressure plasma irradiation on expression levels of matrix metalloproteinases in benign melanocytic tumors in RET-transgenic mice. European Journal of Dermatology. 2014;24(3):392-4.

  • 23.

    Mashayekh S, Rajaee H, Akhlaghi M, Shokri B, Hassan ZM. Atmospheric-pressure plasma jet characterization and applications on melanoma cancer treatment (B/16-F10). Physics of Plasmas. 2015;22(9):093508.

  • 24.

    Park G, Park S, Choi M, Koo I, Byun J, Hong J, et al. Atmospheric-pressure plasma sources for biomedical applications. Plasma Sources Science and Technology. 2012;21(4):043001.

  • 25.

    Kong MG, Kroesen G, Morfill G, Nosenko T, Shimizu T, Van Dijk J, et al. Plasma medicine: an introductory review. new Journal of Physics. 2009;11(11):115012.

  • 26.

    Laroussi M. Low-temperature plasmas for medicine? IEEE Transactions on plasma science. 2009;37(6):714-25.

  • 27.

    Graves DB. The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology. Journal of Physics D: Applied Physics. 2012;45(26):263001.

  • 28.

    Simsek E, Imir N, Aydemir EA, Gokturk RS, Yesilada E, Fiskin K. Caspase-mediated apoptotic effects of Ebenus boissieri barbey extracts on human cervical cancer cell line hela. Pharmacognosy magazine. 2017;13(50):254.

  • 29.

    Kong JN, He Q, Wang G, Dasgupta S, Dinkins MB, Zhu G, et al. Guggulsterone and bexarotene induce secretion of exosomeassociated breast cancer resistance protein and reduce doxorubicin resistance in MDAMB231 cells. International journal of cancer. 2015;137(7):1610-20.

  • 30.

    Santhanam RK, Ahmad S, Abas F, Safinar Ismail I, Rukayadi Y, Tayyab Akhtar M, et al. Bioactive constituents of Zanthoxylum rhetsa bark and its cytotoxic potential against B16-F10 melanoma cancer and normal human dermal fibroblast (HDF) cell lines. Molecules. 2016;21(6):652.

  • 31.

    Prez ZEJ, Mathiyalagan R, Markus J, Kim Y-J, Kang HM, Abbai R, et al. Ginseng-berry-mediated gold and silver nanoparticle synthesis and evaluation of their in vitro antioxidant, antimicrobial, and cytotoxicity effects on human dermal fibroblast and murine melanoma skin cell lines. International journal of nanomedicine. 2017;12:709.

  • 32.

    Guerra FS, de Oliveira RG, Fraga CAM, dos Santos Mermelstein C, Fernandes PD. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells. Scientific reports. 2017;7(1):13723.

  • 33.

    Ja Kim S, Min Joh H, Chung T. Production of intracellular reactive oxygen species and change of cell viability induced by atmospheric pressure plasma in normal and cancer cells. Applied Physics Letters. 2013;103(15):153705.

  • 34.

    Kaushik NK, Kaushik N, Park D, Choi EH. Altered antioxidant system stimulates dielectric barrier discharge plasma-induced cell death for solid tumor cell treatment. PloS one. 2014;9(7):e103349.

  • 35.

    Ishaq M, Evans MD, Ostrikov KK. Atmospheric pressure gas plasma-induced colorectal cancer cell death is mediated by Nox2ASK1 apoptosis pathways and oxidative stress is mitigated by SrxNrf2 anti-oxidant system. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2014;1843(12):2827-37.

  • 36.

    Ishaq M, Kumar S, Varinli H, Han ZJ, Rider AE, Evans MD, et al. Atmospheric gas plasmainduced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosis. Molecular biology of the cell. 2014;25(9):1523-31.

  • 37.

    Kim SJ, Chung T. Cold atmospheric plasma jet-generated RONS and their selective effects on normal and carcinoma cells. Scientific reports. 2016;6:20332.

  • 38.

    Keidar M. Plasma for cancer treatment. Plasma Sources Science and Technology. 2015;24(3):033001.

  • 39.

    Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature reviews Drug discovery. 2009;8(7):579-91.

  • 40.

    Cairns R, Harris I, McCracken S, Mak T, editors. Cancer cell metabolism. Cold Spring Harbor symposia on quantitative biology; 2011: Cold Spring Harbor Laboratory Press.

  • 41.

    Yan D, Talbot A, Nourmohammadi N, Sherman JH, Cheng X, Keidar M. Toward understanding the selective anticancer capacity of cold atmospheric plasmaA model based on aquaporins. Biointerphases. 2015;10(4):040801.

  • 42.

    Thiyagarajan M, Alexeff I, Parameswaran S, Beebe S. Atmospheric pressure resistive barrier cold plasma for biological decontamination. IEEE Transactions on plasma science. 2005;33(2):322-3.

  • 43.

    Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. British journal of cancer. 2011;105(9):1295-301.

  • 44.

    Guerrero-Preston R, Ogawa T, Uemura M, Shumulinsky G, Valle BL, Pirini F, et al. Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells. International journal of molecular medicine. 2014;34(4):941-6.

  • 45.

    Partecke LI, Evert K, Haugk J, Doering F, Normann L, Diedrich S, et al. Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo. BMC cancer. 2012;12(1):1..##.